Phenytoin-d10
(Synonyms: 苯妥英D10,5,5-Diphenylhydantoin-d10) 目录号 : GC48861
An internal standard for the quantification of phenytoin
Cas No.:65854-97-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Phenytoin-d10 is intended for use as an internal standard for the quantification of phenytoin by GC- or LC-MS. Phenytoin is an anticonvulsant agent and active metabolite of fosphenytoin . Phenytoin is formed from fosphenytoin by tissue phosphatases.1 It inhibits neuronal voltage-gated sodium channels in a voltage-dependent manner.2 Phenytoin reduces the neuronal firing frequency and decreases the amplitude of excitatory post-synaptic potentials (EPSPs) in electrically stimulated rat corticostriatal slices (EC50s = 42.8 and 33.5 µM, respectively).3 It protects against seizures induced by maximal electroshock (MES) in mice (ED50 = 10 mg/kg).4 Formulations containing phenytoin have been used in the treatment of tonic-clonic seizures and status epilepticus.
1.Boucher, B.A.Fosphenytoin: A novel phenytoin prodrugPharmacotherapy16(5)777-791(1996) 2.Yaari, Y., Selzer, M.E., and Pincus, J.H.Phenytoin: Mechanisms of its anticonvulsant actionAnn. Neurol.20(2)171-184(1986) 3.Calabresi, P., Centonze, D., Marfia, G.A., et al.An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neuronsBr. J. Pharmacol.126(3)689-696(1999) 4.Brouillette, W.J., Jestkov, V.P., Akhtar, M.S., et al.Bicyclic hydantoins with a bridgehead nitrogen. Comparison of anticonvulsant activities with binding to the neuronal voltage-dependent sodium channelJ. Med. Chem.37(20)3289-3293(1994)
| Cas No. | 65854-97-9 | SDF | |
| 别名 | 苯妥英D10,5,5-Diphenylhydantoin-d10 | ||
| Canonical SMILES | O=C1C(C2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])(C3=C([2H])C([2H])=C([2H])C([2H])=C3[2H])NC(N1)=O | ||
| 分子式 | C15H2D10N2O2 | 分子量 | 262.3 |
| 溶解度 | DMSO : 50 mg/mL (190.60 mM; Need ultrasonic) | 储存条件 | -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.8124 mL | 19.0621 mL | 38.1243 mL |
| 5 mM | 0.7625 mL | 3.8124 mL | 7.6249 mL |
| 10 mM | 0.3812 mL | 1.9062 mL | 3.8124 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet